Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer

Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Dr. Balaji V. Prasad as Chief Strategy Officer.

Read more at globenewswire.com